← Back to all trials
Active Not Recruiting
NCT05645913
Association of Obesity and Cardiovascular Outcomes in Atrial Fibrillation
Conditions: Atrial Fibrillation, Obesity, Prognosis, Anticoagulants
Sex: All
Ages: 20 Years – N/A
Healthy volunteers: 1
Enrollment: 56272
Sponsor: Ajou University School of Medicine
Location: Korea, Republic of
Summary
In this study, the investigators evaluated the association between various measures of adiposity [BMI and waist circumference (WC)] and clinical outcomes in Asian patients with AF who were prescribed OAC, using a nationwide population based cohort.
Eligibility Criteria
Inclusion Criteria:Oral anticoagulant (OAC) new users diagnosed with atrial fibrillation (AF) between January 2015 and December 2020Exclusion Criteria:Patients aged <20 yearsValvular AF patientsPossible alternative indications for OAC (pulmonary embolism, deep vein thrombosis, or recent joint replacement surgery)Cancer patients
Source: ClinicalTrials.gov (NCT05645913). StuddyBuddy aggregates publicly available trial information.
